Log in

NYSE:VAR - Varian Medical Systems Stock Price, Forecast & News

$146.92
+0.01 (+0.01 %)
(As of 02/16/2020 04:00 PM ET)
Add
Today's Range
$145.82
Now: $146.92
$147.20
50-Day Range
$140.22
MA: $145.18
$149.57
52-Week Range
$103.92
Now: $146.92
$150.06
Volume452,364 shs
Average VolumeN/A
Market CapitalizationN/A
P/E Ratio45.77
Dividend YieldN/A
BetaN/A
Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
CUSIP92220P10
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees10,062
Next Earnings Date4/22/2020 (Estimated)
OptionableOptionable

Receive VAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VAR and its competitors with MarketBeat's FREE daily newsletter.


Varian Medical Systems (NYSE:VAR) Frequently Asked Questions

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) released its quarterly earnings results on Wednesday, January, 29th. The medical equipment provider reported $1.16 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $1.21 by $0.05. The medical equipment provider had revenue of $828.90 million for the quarter, compared to analyst estimates of $829.36 million. The company's revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.06 earnings per share. View Varian Medical Systems' Earnings History.

When is Varian Medical Systems' next earnings date?

Varian Medical Systems is scheduled to release their next quarterly earnings announcement on Wednesday, April 22nd 2020. View Earnings Estimates for Varian Medical Systems.

What guidance has Varian Medical Systems issued on next quarter's earnings?

Varian Medical Systems updated its FY20 earnings guidance on Wednesday, January, 29th. The company provided earnings per share (EPS) guidance of $5.30-5.45 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.40.

What price target have analysts set for VAR?

7 analysts have issued 12-month price targets for Varian Medical Systems' stock. Their forecasts range from $157.00 to $171.00. On average, they expect Varian Medical Systems' share price to reach $163.29 in the next year. This suggests a possible upside of 11.1% from the stock's current price. View Analyst Price Targets for Varian Medical Systems.

What is the consensus analysts' recommendation for Varian Medical Systems?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Varian Medical Systems.

What are Wall Street analysts saying about Varian Medical Systems stock?

Here are some recent quotes from research analysts about Varian Medical Systems stock:
  • 1. According to Zacks Investment Research, "Varian exited the fiscal first quarter on a weak note. However, the company continues to gain from its core Oncology Systems segment, which saw solid overseas growth, especially in EMEA and China. In fact, management foresees tremendous opportunities in China owing to the recent tariff exclusions. Gross orders surged in the quarter. Management is optimistic about the recently-closed acquisitions of CyberHeart, Cancer Treatment Services International, Endocare and Alicon. Expansion in gross margin is an added positive. Varian retained its outlook for fiscal 2020. On the flip side, the Proton Solutions unit was weak in the quarter. Moreover, Varian saw some softness in orders in Japan. Reflective of these, the stock has underperformed the industry in a year’s time. The stock is overvalued at the moment." (2/3/2020)
  • 2. Barrington Research analysts commented, "We strongly suspect that radiation that is delivered via the Ethos system will receive very high marks from both clinicians and patients alike. Ethos currently has its CE Mark while a 510(k) regulatory clearance in the U.S. is still pending." (9/23/2019)

Has Varian Medical Systems been receiving favorable news coverage?

Media stories about VAR stock have trended negative on Sunday, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Varian Medical Systems earned a coverage optimism score of -2.3 on InfoTrie's scale. They also assigned news coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Varian Medical Systems.

Are investors shorting Varian Medical Systems?

Varian Medical Systems saw a decrease in short interest in the month of January. As of January 15th, there was short interest totalling 1,660,000 shares, a decrease of 15.7% from the December 31st total of 1,970,000 shares. Based on an average daily trading volume, of 627,300 shares, the short-interest ratio is currently 2.6 days. Approximately 1.8% of the shares of the stock are short sold. View Varian Medical Systems' Current Options Chain.

Who are some of Varian Medical Systems' key competitors?

What other stocks do shareholders of Varian Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varian Medical Systems investors own include NVIDIA (NVDA), Netflix (NFLX), Visa (V), Verizon Communications (VZ), Alibaba Group (BABA), AT&T (T), Thermo Fisher Scientific (TMO), CVS Health (CVS), Align Technology (ALGN) and Illumina (ILMN).

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the folowing people:
  • Mr. Dow R. Wilson, Pres, CEO & Director (Age 60)
  • Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 51)
  • Mr. John W. Kuo, Sr. VP, Gen. Counsel & Corp. Sec. (Age 56)
  • Ms. Kolleen T. Kennedy, Chief Growth Officer & Pres of Proton Solutions (Age 60)
  • Mr. Kevin O'Reilly, Sr. VP of Global Operations

Who are Varian Medical Systems' major shareholders?

Varian Medical Systems' stock is owned by many different of institutional and retail investors. Top institutional shareholders include State Street Corp (4.64%), Loomis Sayles & Co. L P (3.61%), Fiera Capital Corp (3.56%), First Eagle Investment Management LLC (1.46%), FMR LLC (1.45%) and AJO LP (1.30%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, David J Illingworth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.

Which institutional investors are selling Varian Medical Systems stock?

VAR stock was sold by a variety of institutional investors in the last quarter, including Loomis Sayles & Co. L P, AJO LP, Nuance Investments LLC, Bank of America Corp DE, Oakbrook Investments LLC, Schroder Investment Management Group, AQR Capital Management LLC and Great West Life Assurance Co. Can. Company insiders that have sold Varian Medical Systems company stock in the last year include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.

Which institutional investors are buying Varian Medical Systems stock?

VAR stock was bought by a variety of institutional investors in the last quarter, including Marshall Wace North America L.P., Fiera Capital Corp, Los Angeles Capital Management & Equity Research Inc., Madison Asset Management LLC, Skandinaviska Enskilda Banken AB publ , Renaissance Technologies LLC, Banco Santander S.A. and Alyeska Investment Group L.P.. View Insider Buying and Selling for Varian Medical Systems.

How do I buy shares of Varian Medical Systems?

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of VAR stock can currently be purchased for approximately $146.92.


MarketBeat Community Rating for Varian Medical Systems (NYSE VAR)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  518 (Vote Outperform)
Underperform Votes:  452 (Vote Underperform)
Total Votes:  970
MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe VAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VAR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Featured Article: FinTech

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel